A Clinical Study for Those with Sciatica or Leg Pain from a Herniated Disc Is Now Enrolling

GLEN BURNIE, Md., June 24, 2019 /PRNewswire/ -- Explore other options!

A non-steroidal, non-opioidal investigational study medication, already approved for use in Japan [Hernicore®], for those with sciatica or leg pain from a herniated lumbar disc is now being evaluated in a clinical research study in the United States, The Discovery 6603 Study. The study drug, SI-6603, is an investigational drug in the United States and is not yet approved by the Food and Drug Administration. In a Phase 3 study in 163 Japanese subjects, a total of 82 and 81 Japanese subjects received a single injection of SI-6603 or placebo. A single injection of SI-6603 into the nucleus pulposus reduced nerve root compression by reducing disc pressure and volume of herniation, resulting in less leg pain. This clinical research study, the Discovery 6603 Study, is for people who have not responded to other conservative treatments and who are candidates for surgery and is administered as a single injection of SI-6603 and compared with a control injection, (an injection that contains no medication.) One out of two study participants will receive the active study medication.

The Discovery 6603 Study plans to enroll 320 people aged 30 to 70 years old, who have been diagnosed with leg pain from a herniated lumbar disc. Those who qualify for and join the Discovery 6603 Study will see the Study Doctor up to 11 times over 12 months.  Study-related exams, study-related diagnostic tests, and the investigational study medication are provided at no charge.  Study participants may be compensated for their time and travel to the study location.

Millions of Americans are affected by sciatica or leg pain from a herniated lumbar disc and often resort to common treatments that contain steroids or opioids.

The Discovery 6603 Study is being conducted at:

• Samaritan Center for Medical Research – Los Gatos, CA
• The Helm Center for Pain Management – Laguna Woods, CA
• UC Davis Health – Sacramento, CA
• University of California San Diego – Center for Pain Medicine – La Jolla, CA
• DBPS Research, LLC – Greenwood Village, CO
• AMPM Research Clinic – Miami Gardens, FL
• Genoma Research Group, Inc. – Miami, FL
• National Pain Research Institute, LLC – Winter Park, FL
• Orthopaedic Center of South Florida – Plantation, FL
• River City Clinical Research – Jacksonville, FL
• South Florida Clinical Research, LLC – South Miami, FL
• Tampa Pain Relief Center – Tampa, FL
• Chicago Anesthesia Pain Specialist – Chicago, IL
• Millennium Pain Center – Bloomington, IL
• Indiana Spine Group – Carmel, IN
• Mid America PolyClinic – Pain Med – Overland Park, KS
• Clinical Trials of Southwest Louisiana (SWLA), LLC – Lake Charles, LA
• Orthopaedic Associates of Michigan – Grand Rapids, MI
• Interventional Spine Medicine – Barrington, NH
• Main Line Spine – King of Prussia, PA
• Clinical Trials of South Carolina – Charleston, SC
• Coastal Carolina Research Center – North Charleston, SC
• Department of Orthopedic Surgery University of Virginia School of Medicine, The Spine Clinic, Fontaine Research Park – Charlottesville, VA
• Gershon Pain Specialists – Virginia Beach, VA

For more information about the Discovery 6603 Study and to see if you or someone you love may qualify, please call 877-770-1411 or visit www.TheDISCoveryStudy.com.

MEDIA CONTACT:
Barb Evans
Senior Project Manager
[email protected] 
443.308.5816

SOURCE The Discovery Study

Related Links

http://www.thediscoverystudy.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED